根治性前列腺切除术后膀胱尿道吻合口活检:指导挽救性放疗的被遗忘工具
本研究回顾性分析2015年1月至2020年8月间18例根治性前列腺切除术后生化复发且68Ga-PSMA PET/CT未显示前列腺床复发的患者,这些患者接受了经会阴超声引导的膀胱尿道吻合口(VUA)定向活检。结果显示,7/18例活检证实VUA处复发前列腺癌,而68Ga-PSMA PET/CT均未显示该处摄取。结论提示VUA定向活检可辅助决策挽救性放疗,尤其当PET/CT局部阴性时。
要点
- 68Ga-PSMA PET/CT局部阴性不能排除VUA处局部复发。
- VUA定向活检在7/18例中检出复发前列腺癌。
- PET/CT与活检均阴性时,应共同决策挽救性放疗或继续监测。
核心结论
- VUA定向活检可能有助于指导根治性前列腺切除术后生化复发患者的挽救性放疗决策,尤其当68Ga-PSMA PET/CT局部阴性时。
研究设计与样本
- 回顾性分析2015年1月至2020年8月前瞻性维护的数据库,纳入18例根治性前列腺切除术后生化复发(PSA>0.2 ng/mL)且68Ga-PSMA PET/CT未显示前列腺床复发的患者,均接受经会阴超声引导的VUA定向活检。
主要发现
- 68Ga-PSMA PET/CT显示18例中无1例VUA摄取,2/18例精囊腺摄取,2/18例区域淋巴结摄取。
- VUA定向活检组织学显示6/18例无前列腺组织,12/18例有前列腺组织。
- 7/18例活检证实VUA处复发前列腺癌,而68Ga-PSMA PET/CT未显示阳性。
临床怎么用
- 对于根治性前列腺切除术后生化复发且68Ga-PSMA PET/CT局部阴性的患者,可考虑行VUA定向活检以协助判断是否存在局部复发。
- 当68Ga-PSMA PET/CT和VUA定向活检均阴性时,应鼓励临床医生与患者共同决策是否行挽救性放疗或继续生化复发监测,可能延迟挽救性放疗相关副作用。
局限性
- 回顾性研究,样本量小(18例),来自单中心前瞻性维护数据集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To review the utility of vesicourethral anastomosis (VUA)-directed biopsy in the setting of biochemical recurrence (BCR) after radical prostatectomy (RP) for prostate cancer (PCa) in patients who have undergone evaluation by gallium-68 prostate-specific membrane antigen positron emission tomography with computed tomography (68 Ga-PSMA PET/CT). METHODS: We completed a retrospective review of a prospectively maintained dataset from January 2015 to August 2020. Patient demographics were recorded for those who experienced BCR, as defined by a rise in prostate-specific antigen (PSA) level to above 0.2 ng/mL, who had a 68 Ga-PSMA PET/CT that did not demonstrate recurrence within the prostate bed, and who subsequently underwent a transperineal ultrasonography (TPUS)-guided biopsy directed at the VUA. Histological reporting of the biopsies was undertaken in order to determine whether the benefits of salvage radiation therapy (SRT) could be justified by the presence of cancer cells. RESULTS: Eighteen patients who had a 68 Ga-PSMA PET/CT and underwent VUA-directed biopsy were identified as having BCR. 68 Ga-PSMA PET/CT scans demonstrated avidity at the VUA in none of the patients, although two out of 18 patients showed avidity in the seminal vesicles and two out of 18 patients showed avidity within regional lymph nodes. Histology from the TPUS-guided, VUA-directed biopsies demonstrated no prostatic tissue in six out of 18 and presence of prostatic tissue in 12 out of 18 of patients, respectively. In 7 out of 18 cases, there was histological evidence of recurrent PCa at the VUA in the absence of a positive 68 Ga-PSMA PET/CT scan. CONCLUSION: This study highlights the potential value of VUA-directed biopsy. We are reminded that a negative 68 Ga-PSMA PET/CT does not exclude local recurrence and that the addition of a VUA-directed biopsy may aid in the decision-making process for patients with BCR following RP, especially when 68 Ga-PSMA PET/CT is locally negative. When the result of both 68 Ga-PSMA PET/CT and VUA-directed biopsy are negative, it should encourage clinicians to share decision-making in regard to undertaking SRT vs continuing BCR surveillance. This may delay the possible side effects associated with SRT, despite its excellent PSA failure-free survival rate.
引用
- Timm B, Farag M, Liodakis P, et al. Vesico-urethral anastomosis sampling: a forgotten tool for guiding salvage radiation after radical prostatectomy. BJU Int. 2021. PMID: 33973332. doi:10.1111/bju.15315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。